Favit-Van Pelt Antonella R. 4

4 · HELIUS MEDICAL TECHNOLOGIES, INC. · Filed Jul 8, 2021

Insider Transaction Report

Form 4
Period: 2021-07-07
Favit-Van Pelt Antonella R.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-07-07+18,00018,000 total
    Exercise: $16.45Exp: 2031-07-06Common Stock (18,000 underlying)
Footnotes (1)
  • [F1]Grant to the Reporting Person of a stock option under the Issuer's 2021 Inducement Plan. The options vest in four equal installments on each of the first, second, third and fourth anniversaries of the date of grant, subject to the Reporting Person's continued service through each applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION